AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionAprio Wealth Management, LLC
Latest Disclosed Ownership10,305 shares
Latest Disclosed Value $ 2,241,310
Aprio Wealth Management, LLC reports 1.52% decrease in ownership of 4AB / AbbVie Inc.

On May 11, 2026 - Aprio Wealth Management, LLC filed a 13F-HR form disclosing ownership of 10,305 shares of AbbVie Inc. (BG:4AB) valued at $2,241,310 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 10,464 shares of AbbVie Inc.. This represents a change in shares of -1.52% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ABBVIE COM 00287Y109 10,305 -159 -1.52 2,241 -6.23 0.1224
2026-01-29 2025-12-31 13F ABBVIE COM 00287Y109 10,464 4,502 75.51 2,391 73.19 0.1372
2025-11-12 2025-09-30 13F ABBVIE COM 00287Y109 5,962 655 12.34 1,380 40.24 0.1373
2025-08-14 2025-06-30 13F ABBVIE COM 00287Y109 5,307 -717 -11.90 985 -22.03 0.1111
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 6,024 517 9.39 1,262 29.04 0.1581
2025-01-13 2024-12-31 13F ABBVIE COM 00287Y109 5,507 301 5.78 979 -4.86 0.1428
2024-10-08 2024-09-30 13F ABBVIE COM 00287Y109 5,206 1,265 32.10 1,028 52.30 0.1644
2024-07-10 2024-06-30 13F ABBVIE COM 00287Y109 3,941 -3 -0.08 676 -5.99 0.1231
2024-04-10 2024-03-31 13F ABBVIE COM 00287Y109 3,944 1,136 40.46 718 65.06 0.1408
2024-01-17 2023-12-31 13F ABBVIE COM 00287Y109 2,808 -652 -18.84 435 -15.53 0.0972
2023-10-10 2023-09-30 13F ABBVIE COM 00287Y109 3,460 3,460 516 0.1417
2023-07-13 2023-06-30 13F ABBVIE COM 00287Y109 0 -1,697 -100.00 0 -100.00
2023-04-14 2023-03-31 13F ABBVIE COM 00287Y109 1,697 160 10.41 271 8.87 0.0833
2023-01-11 2022-12-31 13F ABBVIE COM 00287Y109 1,537 1,537 248 0.0874
2022-10-13 2022-09-30 13F ABBVIE COM 00287Y109 0 -1,954 -100.00 0 -100.00
2022-07-26 2022-06-30 13F ABBVIE COM 00287Y109 1,954 1,954 299 0.1191
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.